Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENvue Medical (FEED) Assets (2017 - 2025)

Historic Assets for ENvue Medical (FEED) over the last 12 years, with Q3 2025 value amounting to $54.4 million.

  • ENvue Medical's Assets rose 106153.35% to $54.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $54.4 million, marking a year-over-year increase of 106153.35%. This contributed to the annual value of $3.6 million for FY2024, which is 4562.48% down from last year.
  • According to the latest figures from Q3 2025, ENvue Medical's Assets is $54.4 million, which was up 106153.35% from $51.5 million recorded in Q2 2025.
  • Over the past 5 years, ENvue Medical's Assets peaked at $54.4 million during Q3 2025, and registered a low of $3.6 million during Q4 2024.
  • For the 5-year period, ENvue Medical's Assets averaged around $13.3 million, with its median value being $6.7 million (2023).
  • Its Assets has fluctuated over the past 5 years, first crashed by 4609.97% in 2022, then soared by 106153.35% in 2025.
  • Over the past 5 years, ENvue Medical's Assets (Quarter) stood at $8.6 million in 2021, then plummeted by 31.81% to $5.9 million in 2022, then increased by 13.52% to $6.7 million in 2023, then tumbled by 45.62% to $3.6 million in 2024, then surged by 1398.57% to $54.4 million in 2025.
  • Its Assets was $54.4 million in Q3 2025, compared to $51.5 million in Q2 2025 and $44.1 million in Q1 2025.